D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Microsoft
MSFT
|
+$549M |
| 2 |
Tesla
TSLA
|
+$538M |
| 3 |
Pinduoduo
PDD
|
+$357M |
| 4 |
Intel
INTC
|
+$261M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$255M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$398M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$300M |
| 3 |
Procter & Gamble
PG
|
+$281M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 5 |
JPMorgan Chase
JPM
|
+$250M |
Sector Composition
| 1 | Technology | 20.4% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 11.45% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MZTI
2226
The Marzetti Company Common Stock
MZTI
$5.02B
| $1.09M | ﹤0.01% |
+5,524
| New | +$1.09M |
|
2227
Zura Bio
ZURA
$125M
| $1.09M | ﹤0.01% |
106,597
| – | – |
|
2228
Fulgent Genetics
FLGT
$673M
| $1.09M | ﹤0.01% |
36,496
+10,026
| +38% | +$299K |
|
2229
Haleon
HLN
$43.3B
| $1.09M | ﹤0.01% |
135,717
+89,810
| +196% | +$718K |
|
|
LBAI
2230
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.08M | ﹤0.01% |
61,484
+25,471
| +71% | +$449K |
|
|
NOA
2231
North American Construction
NOA
$399M
| $1.08M | ﹤0.01% |
81,000
+26,700
| +49% | +$356K |
|
2232
PDF Solutions
PDFS
$776M
| $1.08M | ﹤0.01% |
37,883
+12,907
| +52% | +$368K |
|
|
PINE
2233
Alpine Income Property Trust
PINE
$208M
| $1.08M | ﹤0.01% |
+56,571
| New | +$1.08M |
|
2234
Monster Beverage
MNST
$62.8B
| $1.07M | ﹤0.01% |
21,090
+4,126
| +24% | +$209K |
|
|
NESRW
2235
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
| $1.07M | ﹤0.01% |
+2,669,578
| New | +$1.07M |
|
2236
Clearwater Analytics
CWAN
$5.66B
| $1.07M | ﹤0.01% |
56,908
+32,251
| +131% | +$605K |
|
2237
Pixelworks
PXLW
$53.8M
| $1.07M | ﹤0.01% |
50,207
+998
| +2% | +$21.2K |
|
2238
iQIYI
IQ
$2.47B
| $1.07M | ﹤0.01% |
201,108
+53,071
| +36% | +$281K |
|
2239
Schneider National
SNDR
$4.19B
| $1.06M | ﹤0.01% |
+45,492
| New | +$1.06M |
|
|
HPLT
2240
DELISTED
Home Plate Acquisition Corporation Class A Common Stock
HPLT
| $1.06M | ﹤0.01% |
105,000
| – | – |
|
2241
Sun Life Financial
SLF
$33.5B
| $1.06M | ﹤0.01% |
22,871
-409,599
| -95% | -$19M |
|
|
MYOV
2242
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.06M | ﹤0.01% |
39,213
-2,644
| -6% | -$71.3K |
|
|
HTB
2243
HomeTrust Bancshares, Inc.
HTB
$713M
| $1.06M | ﹤0.01% |
43,657
-6,742
| -13% | -$163K |
|
2244
Carpenter Technology
CRS
$12B
| $1.05M | ﹤0.01% |
28,556
-27,867
| -49% | -$1.03M |
|
|
SOVO
2245
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $1.05M | ﹤0.01% |
73,398
-21,638
| -23% | -$311K |
|
|
BLUE
2246
DELISTED
bluebird bio
BLUE
| $1.05M | ﹤0.01% |
7,618
+5,159
| +210% | +$714K |
|
|
CDAQ
2247
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
| $1.05M | ﹤0.01% |
105,005
| – | – |
|
2248
Cullinan Oncology
CGEM
$375M
| $1.05M | ﹤0.01% |
99,701
+22,261
| +29% | +$235K |
|
2249
Preferred Bank
PFBC
$1.15B
| $1.05M | ﹤0.01% |
+14,094
| New | +$1.05M |
|
2250
Karyopharm Therapeutics
KPTI
$54.3M
| $1.05M | ﹤0.01% |
20,531
+10,944
| +114% | +$558K |
|